Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises a consortium of Swedish and foreign banks in connection with the financing of the New Karolinska Hospital in Solna
Mandate

Vinge advises a consortium of Swedish and foreign banks in connection with the financing of the New Karolinska Hospital in Solna

July 05, 2010

Vinge and Clifford Chance have advised a consortium of Swedish and foreign banks in connection with the financing of the New Karolinska Hospital in Solna which will be built, run and maintained by Skanska and Innisfree on behalf of Stockholm County Council. The project is Skanska’s largest project to date with a total project value of approximately SEK 14.5 billion. This is also the second Swedish so-called PPP (Public Private Partnership) after the Alranda railway and, when completed in 2015, the new Karolinska Hopistal will be the world’s largest PPP hospital.

Vinge’s team consisted of partner Maria-Pia Midenbäck Hope and, among others, associates Dan Hanqvist, Maria Schultzberg, Peter Forsberg, Christina Rosén, Sofia Berg and Albert Wållgren.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025